Attend the FierceBiotech Executive Breakfast at BIO 2019
Join us on June 5th for our panel discussion on real-world evidence. Reserve your seat today.
Incoming FDA Commissioner Ned Sharpless used his first official talk to ensure we all know he’s not looking to tear up Scott Gottlieb’s legacy.
Charles River Labs and the CHDI Foundation have signed a five-year extension for their Huntington’s disease work.
California life sciences companies Twist Bioscience and LakePharma have penned a new pact to offer antibody discovery services to biopharma clients.
Concerto HealthAI has inked its second real-world data collaboration with a Big Pharma company in as many weeks.
WuXi AppTec has hired Frederick Hausheer, M.D., as it looks to mine his clinical trial expertise for its boosted drug development offerings.
One man (and bookies’ favorite to be the next prime minister) is talking about cutting red tape surrounding clinical trials.
Looking to boost its offerings in central nervous system trials, Evolution Research Group has bought up New York-based Finger Lakes Clinical Research.
After a number of pacts and buyouts over the past few years, Charles River Labs is cutting staff at one of its California sites.
LabCorp tapped Mission Bio to provide single-cell DNA analysis in a collaboration with its Covance drug development arm.
Bristol-Myers Squibb has tapped Concerto HealthAI for a multiyear, real-world data project covering a range of different cancers.
